ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

